#Cancerstatistics

A major new report brings much-needed relief to the global cancer community, revealing that advanced cancer diagnoses in the United States—which spiked during the early days of the COVID-19 pandemic—have now returned to levels seen before the global crisis. Published Monday in the journal Cancer, the study offers a broad analysis of U.S. cancer statistics, addressing widespread fears that disruptions to screening during the pandemic would drive a lasting increase in late-stage cancer cases and, ultimately, higher death rates (AP News).

A major new analysis offers relief to the global cancer community: advanced cancer diagnoses in the United States have largely returned to pre-pandemic levels after a spike during the COVID-19 crisis. The study, published in Cancer, examined U.S. cancer statistics and found that disruptions to screening did not cause a lasting rise in late-stage cancers or cancer deaths. This insight provides guidance for policymakers and health planners in Thailand as the country redoubles its screening efforts.